This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Kubinyi. H., QSAR: Hansch analysis and related approaches, VCH, Weinheim. 1993.
Kubinyi, H. (Ed.), 3D-QSAR in drug design: Thory methods and applications, SCOM, Leiden, 1993.
Kuntz, I.D., Structure-basedstrategies for drug designed and discovery, Science 257 (1992) 1078–1082.
Blundell, T.L., Structure-based drug design. Nature, 381 Suppl. (1996) 23–26
Greer, J., Erickson, J.W., Baldwin, J.J. and Varney, M.D., Application of the three-dimensional structures of protein target molecules in structure-based drug design, J. Med. Chem., 37 (1994) 1035–1054.
Hogan, J.C., Directed combinatorial chemistry. Nature, 384 Suppl. (1996) 17–19.
Ortiz, A.R., Pisabarro, M.T., Gago F. and Wade, R.C., Prediction of drug binding affinites by comparative binding energy analysis, J. Med. Chem., 38 (1995) 2681–2691.
Ortiz, A.R., Pisabrro, M.T., Gago. F. and Wade, R.C., Prediction of drug binding affinites by comparative binding energy analysis: Application to human synovial fluid phospholipase A 2 Inhibitors, In QSAR and molccular modelling: Concepts. computational tools and biological applications, Sanz. F., Giraldo. J. and Manaut, F. (Eds.) J.R. Prous, Barcelona. 1995, pp. 439–443.
Cramer III, R.D., Patterson, D.E. and Bunce. J.D., Comparative molecular field analysis (CoMFA): 1. Effect of shape on binding of steroids to carrier proteins, J. Am. Chem. Suc., 110 (1988) 5959–5067.
Straatsma. T.P. and McCammon, J.A., computational alchemy, Ann. Rev. Phys. Chem., 43 (1992) 407–435.
Kollman, P., Free energy calculation: Application to chemical and biochemical phenomena Chem. Rev., 93 (1993) 2395–2417
Blancy, J.M., Weiner, P.K., Dearing, A., Kollman, P.A., Jorgensen, E.C., Oatley, S.J., Burridge, J.M. and Blake, C.C.F., molecular mechanics simulation of protein-ligand interactions: Binding of thyroid hormone analogues to prealbumin, J. AM. Chem. soc., 104 (1982) 6424–6434.
Menziani, M.C., De Benedeti, P.G., Gago. F. and Richards, W.G.. The binding of benzene sulfonamides to carbonic anhydrase enzyme: A molecular mechanics study and quantitative structure-activity relationship, J. Med. Chem., 32 (1989) 951–956.
Holloway. M.K., Wai, J.M., Halgren, T.A., Fitzgerald, P.M.D., Vacca, J.P., Dorsey, B.D., Levin, R.B., Thompson, W.J., Chen. L.J., deSolms, S.J., Gaffin, N., Ghosh, A.K., Giuliani, E.A., Graham, S.L., Guare, J.P., Hungate, R.W., Lyle. T.A., Sanders, W.M., Tucker, T.J., Wiggins, M., Wiscount, C.M., Woltersdorf, O.W., Young, S.D., Darle. P.L. and Zigay, J.A. A priori prediction of activity for HIV-1 protease inhibitors employing energy minimization in the active site, J. Med. Chem., 38 (1995) 305–317.
Grootenhuis, P.D.J. and van Galen, P.J.M., Correlation of binding affinties with non-bonded interaction energies of thrombin-inhibitor complexes, Acta Cry st., D51 (1995) 560–566.
Åqvist, J., Medina, C. and Samnelsson, J.E., A new method for predicting binding affinity in computeraided drug design, Prot. Eng., 7 (1994) 385–391
Böhm, H.-J., The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure J. Comput-Aided Mol. Design. 8 (1994) 243–256.
Head, R.D. Smythe, M.L., Oprea, T.I., Waller, C.L., Green, S.M. and Marshall, G.R., VALIDATE: A new method for the receptor-based prediction of binding affinites of novel ligands. J. Am. Chem. soc., 118 (1996) 3959–3969.
Ortiz, A.R., Pastor, M., Palomer, A., Cruciani, G., Gago, F. and Wade, R.C.. Reliability of comparative molecular field analysis models: Effects of data scaling and variable selection using a set of human synovial phospholipase A2 inhibitors, J. Med. Chem. (1997) 40. 1136–1148.
Honig, B. and Nicholls, A., Classical electrostatics in biology and chemistry, Science, 268 (1995) 1144–1149.
Wold, S., PLS-partial least squares projections to latent structures. In 3D-QSAR in drug dcsign: Theory. methods and applications. Kubinyi, H. (Ed.). ESCOM. Leiden. 1993. pp. 523–550.
Baroni, M., Constantino, G., Cruciani, G., Riganelli, D., Valigi. R. and Clementi, S., Generating optimal linear PLS estimations (GOLPE): An advanced chemometric tool for handling 3DQSAR problems, Quant. Struct.-Act. Relat., 12 (1993) 9–20.
Schevitz, R.W., Bach, N.J., Carlson, D.G., Chrigadze, N.Y., Clawson, D.K., Dillard, R.D., Draheim, S.E., Hartley, L.W., Jones, N.D., Mihelich, E.D., Olkowski, J.L., Snyer, D.W, Sommers, C. and Wery, J.-P., structure-based design of the first potent and selective inhibitor of human non-pancreatic secretary Phospholipase A 2, Nat. Struct. Biol., 2 (1995) 458–465.
cornell, W.D., Cieplak, P., Bayly, C.I., Gould, I.R., Merz, K.M., Ferguson, D.M., Spellmeyer, D.C., Fox, T., Caldwell, J.W. and Kollman, P A., A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J. Am. Chem. Soc., 117 (1995) 5179–5197.
Gilson, M.K., Sharp, K.A. and Honig, B.H., Calculating the electrostatic potential of molecules in rolution: Method and error assessment, J. comput. Chem., 9 (1987) 327–335.
Wheeler, T.N., Elanchard, S.G., Andrew, R.C., Fang, F., Gray-Nunez, Y., Harris, C.O., Lambert, M.H., Mehrotra, M.M., Parks, D.J., Ray, J.A. and Smalley, T.L., substrate specificity in short-chain phospholipid analogs at the active site of human synovial phospholipase A 2, J. Med. Chem., 37 (1995) 4118–4129.
Ajay and Murcko, M.A., Computational methods to predict binding free energy in ligand—receptor complexes, J. Med. Chem., 38 (1995) 4952–4967.
Gilson, M.K., Given, J.A., Bush, B.L. and McCammon, J.A., Thestatistical thermodynamic basis for computation of binding affinites: a critical review, Biophys. J., 72 (1997) 1047–1069.
Lybrand, T.P., Ligand-protein docking and rational drug design, Curr. Op. Str. Biol. 5 (1995) 224–228.
Checa, A., Ortiz, A.R., de Pascual Teresa, B. and Gogo, F., Assessment of solvation effects on calculated binding affinity differences: Trypsin inhibition by flavonoids as a model system for congeneric series. Med. Chem., in press.
Mattos, C. and Ringe, D., Multiple binding modes. In 3D QSAR in Drug design: Theory, methods and applications, Kubinyi, H., (Ed.) ESCOM. Leiden 1993, pp. 226–254.
Kraulis, P.J., MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures, J. Appl. Crystallog., 24 (1991) 946–950.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Wade, R.C., Qrtiz, A.R., Gago, F. (2002). Comparative Binding Energy Analysis. In: Kubinyi, H., Folkers, G., Martin, Y.C. (eds) 3D QSAR in Drug Design. Three-Dimensional Quantitative Structure Activity Relationships, vol 2. Springer, Dordrecht. https://doi.org/10.1007/0-306-46857-3_2
Download citation
DOI: https://doi.org/10.1007/0-306-46857-3_2
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-4790-3
Online ISBN: 978-0-306-46857-5
eBook Packages: Springer Book Archive